EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disentangling the Link Between Testosterone, Oestrogen, Thyroid Replacement and Mood: Interrupted Time‐Series Analyses of the Australian Pharmaceutical Benefits Scheme Database

Osvaldo P. Almeida, Amy Page, Frank M. Sanfilippo, David B. Preen, Christopher Etherton‐Beer

Pharmacoepidemiology and Drug Safety · 2026-11 · 35 (11)

DOI: 10.1002/pds.70532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 15.11.2026. Verfasst von Osvaldo P. Almeida und 4 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To determine if therapy with testosterone, oestrogen, or thyroid hormones is associated with a decrease in the proportion of individuals dispensed antidepressants.

Methods

Participants were males and females aged 18 years or older in 2013 who were included in the 10% random sample of the Australian Pharmaceutical Benefits Scheme (PBS) database between 1 January 2013 and 31 December 2024. We used interrupted time‐series analysis (ITSA) to examine the association between hormonal treatment started during 2019 and the supply of antidepressants to the population before and after the intervention.

Results

During 2019, testosterone was supplied to 291 males and oestrogen to 10 997 females, and thyroid hormones to 1191 males and 4384 females. Antidepressants were supplied to 33.3% of males treated with testosterone, 26.7% of females dispensed oestrogen, and 19.5% and 23.0% of males and females who received a thyroid hormone. ITSA showed that the introduction of treatment with testosterone in 2019 was associated with a reduced proportion of males dispensed antidepressants by 0.5% per year. The introduction of oestrogen during 2019 was associated with a post‐treatment increase of dispensing of antidepressants for females of 0.6% per year. Thyroxin initiated in 2019 was associated with stable dispensing of antidepressants for males, but antidepressant dispensing increased by 0.5% per year for females.

Conclusions

Oestrogen and thyroid hormones appear to have a non‐significant or negligible association with antidepressant dispensing among females. In contrast, hormonal replacement with testosterone and thyroxin is associated with reduced antidepressant dispensing among males.

Zitieren

APA

Almeida, O. P., Page, A., Sanfilippo, F. M., Preen, D. B., & Etherton‐Beer, C. (2026). Disentangling the Link Between Testosterone, Oestrogen, Thyroid Replacement and Mood: Interrupted Time‐Series Analyses of the Australian Pharmaceutical Benefits Scheme Database. Pharmacoepidemiology and Drug Safety, 35(11). https://doi.org/10.1002/pds.70532

Vancouver

Almeida OP, Page A, Sanfilippo FM, Preen DB, Etherton‐Beer C. Disentangling the Link Between Testosterone, Oestrogen, Thyroid Replacement and Mood: Interrupted Time‐Series Analyses of the Australian Pharmaceutical Benefits Scheme Database. Pharmacoepidemiology and Drug Safety. 2026;35(11). doi:10.1002/pds.70532

BibTeX
@article{Almeida2026,
  author = {Almeida, Osvaldo P. and Page, Amy and Sanfilippo, Frank M. and Preen, David B. and Etherton‐Beer, Christopher},
  title = {Disentangling the Link Between Testosterone, Oestrogen, Thyroid Replacement and Mood: Interrupted Time‐Series Analyses of the Australian Pharmaceutical Benefits Scheme Database},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {11},
  doi = {10.1002/pds.70532}
}
Kostenlos starten →